Study identifier:D1843R00258
ClinicalTrials.gov identifier:NCT02578563
EudraCT identifier:N/A
CTIS identifier:N/A
SGLT2 inhibitor Registry in Singapore
Diabetes Mellitus
N/A
No
-
All
201
Observational
18 Years - 75 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2019 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|